Structural insights into cholesterol sensing by the LYCHOS-mTORC1 pathway
Shang Juan YuiD, Jin-hui Ding, Jiale WangiD, Weize WangiD, Peng ZuoiD, Ao YangiD, Zonglin DaiiD, Yuxin YiniD, Jin‐Peng SuniD, Ling LiangiD
Abstract
The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cellular metabolism and growth by coordinating nutrient resources, including cholesterol, and its aberrant activation is linked to various age-related diseases. LYCHOS is a cholesterol sensor on the lysosome and bound to the GATOR1 complex, a GTPase-activating protein for the Rag GTPase, at high cholesterol concentrations, thereby activating the protein kinase mTORC1. However, how LYCHOS senses cholesterol and transduces signal to GATOR1 remain largely unknown. Here we report six cryo-electron microscopy structures of human LYCHOS, depicting five distinct states. These are categorized into a contracted state when complexed with a sufficient amount of the cholesterol analogue cholesteryl hemisuccinate (CHS), and an expanded state when CHS is deficient. The structure forms a homodimer, within each monomer the transmembrane region is divided into a permease-like domain (PLD) and a GPCR-like domain (GLD) with two clearly defined adjacent cholesterol binding sites between them. The PLD shares a conserved Na+/H+ antiporter (NhaA) fold, which much resembles plant auxin transporter PINs. Cholesterol locates between PLD and GLD and cholesterol binding induces a translation of GLD towards PLD and exposes the cytosolic extension of transmembrane 15, which mediates the interaction between LYCHOS and GATOR1. Strikingly, structure-guided mutations of Gly702 in GLD of LYCHOS increase its affinity for cholesterol, leading to sustained mTORC1 activation in cells. This indicates that LYCHOSs moderate affinity for cholesterol is crucial as a cholesterol sensor. Our results not only showed a solute carrier mechanistically coordinates a GPCR domain, elucidating the structural mechanism of cholesterol sensing by the mTORC1 pathway on the lysosome; but also provides a structural basis for developing inhibitors that selectively target to mTORC1 pathway to treat age-related diseases by blocking LYCHOS in its expanded state.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.66
- Field percentile
- top 17%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ER-Lysosome Cholesterol Exchange Regulates Lysosomal Motility Through mTOR-Dependent LAMTOR1 Phosphorylation
Pathma Muthukottiappan, Alireza Dehghani, … Dominic Winter·bioRxiv·Mar 31, 2026
- Structure and Function of TM6SF1 Reveal Role in mTORC1 Signaling
Sen Hong, Liangjie Jia, … Xiaochun Li·Proceedings of the National Academy of SciencesPeer-reviewed·Sep 14, 2026
- Structural basis for growth factor and nutrient signal integration on the lysosomal membrane by mTORC1
Zhicheng Cui, Alessandra Esposito, … James H. Hurley·NaturePeer-reviewed·Sep 17, 2025
- Cryo-EM structures of human GPR155 elucidate its regulatory and transport mechanisms
Mansi Sharma, Dabbu Kumar Jaijyan, … Appu Kumar Singh·bioRxiv·Sep 24, 2024
- NPC1-mTORC1 signaling Couples Cholesterol Sensing to Organelle Homeostasis and is a Targetable Pathway in Niemann-Pick type C
O. B. Davis, H. R. Shin, … R. Zoncu·bioRxiv·Aug 2, 2020
- HR3/RORα-mediated cholesterol sensing regulates TOR signaling
Mette Lassen, Keith Pardee, … Kim Rewitz·Nature CommunicationsPeer-reviewed·Mar 30, 2026